i L, et al. Potential therapeutic role of para aortic lymphadenecaomy in nonode-positive endometrial cancet[J]. Gynecol Pncol, 2000,76(3):348356
6 Marrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgicalpathological rich factors and outcome in clinical stage I and Ⅱ carcinoma of the endlometrium: a Gunecologic: Oncology Group study [J].Gynecol Oneol, 1991, 40(1):5565
7 Genes P. Stage Ⅲ carcinoma of the endomentrium: a review of 41 cases [J]. Gynecol Oncol, 1987, 26(1):7786
8 Lurain JR, Rice BL, Rademarker AW, et al. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium [J]. Ohstet Gynecol, 1991, 78(1):6369
9 Fanning J, Oreen J B, Oreen S, et al. Oarhoplatin therapy in advanced endometrial cancer[J]. Obstert Gynecol, 1996, 174: 529
10 Mohan D S. Treatment of stage 2 endometrial carinoma[J]. Gynecol Oncol, 1998, 70:165
11 刘炽明译.妇科肿瘤问题[M].北京：人民卫生出版社,1992.116
12 张天泽,徐光炜,主编.肿瘤学[M].天津：天津科技出版社,1996.1935
13 Orr J W, Smith M R, Peters WA. Gisplatin, doxorubicin hydrochloride and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinome[J]. Am J Obsted Gynecol, 1997, 176:777
14 邵淑丽.67例子宫内膜癌综合治疗临床分析[J].肿瘤研究与临床,1996,8(2):115
15 Kilgore L C. StageⅡendometrial carcinoma prognostic factors and the results of treament[J]. Gynecol Oncol,1995,56:29
16 Ber A A, Sutton G. Hormonal aspects of endometrial cancer current opinions[J]. Acta Obstet Gynecol scand,1998,77:347
17 刘新民,赵 晶,万小萍,等.子宫内膜癌手术范围的前瞻性临床研究[J].中华妇产科杂志,1996,31(9):458
18 Chuang L, Hoffman M S, Roberts W S, et al. Treatment of recarrent and metastatic endometrial cancer with cisplatin doxorubicin, cyc Lophosphamide and megestrol acetate[J].Gynecol Oncol,1995,58:189
19 张惜阴.子宫内膜癌的远期随访[J].中华妇产科杂志,1985,20(3):157
20 汤钊猷主编.现代肿瘤学[M].上海：上海医科大学出版社,1993.938
21 孙建衡,李爱苓,张询,等.子宫内膜癌单纯放射治疗回顾性分析[J].中华肿瘤杂志,1991,13(5):375
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 妇产科论文 >> 正文